Genometrix to Validate Osteoporosis SNPs in Japanese Study

May 09, 2001

NEW YORK, May 9 - Genometrix will work with Nippon Medical School in Tokyo to validate osteoporosis-related SNPs in the Japanese population, the company said Wednesday.

In the study, researchers at Nippon Medical School will screen 100 SNPs against 1,200 clinical patient samples using Genometrix's VistaMorph genotyping technology. They will then use the osteoporosis-related SNPs they find to develop a microarray-based diagnostic and treatment system using Genometrix’s VistaArray microarrays.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Halt Under Consideration

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

How's It Going to Go Over?

The Associated Press reports that gene-edited food may soon be for sale.

Meetings on Fetal Research

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

This Week in Cell

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.

Main menu